Commitments and Contingencies - Additional Information (Details)	1 Months Ended	6 Months Ended
	Aug. 31, 2020	Jun. 30, 2022
Commitments And Contingencies [Line Items]
Lease arrangement, contractual expiration period, beginning year		2022
Lease arrangement, contractual expiration period, ending year		2033
Lessee, operating lease, existence of option to extend [true false]		true
Lessee, operating lease, option to extend		These leases require monthly lease payments that may be subject to annual increases throughout the lease term. Certain lease agreements also provide the Company with the option to renew for additional periods ranging from one to five years.
GSKTSL | WuXi Biologics MSA and Samsung MSA | Antibody Program
Commitments And Contingencies [Line Items]
Percentage of development costs	72.50%
GSK | WuXi Biologics MSA and Samsung MSA | Antibody Program
Commitments And Contingencies [Line Items]
Percentage of development costs responsible by GSK	27.50%
Minimum [Member]
Commitments And Contingencies [Line Items]
Lessee, operating lease, renewal term		1 year
Maximum
Commitments And Contingencies [Line Items]
Lessee, operating lease, renewal term		5 years